Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that an analysis of the company has been published by Mangold Insight.
The company analysis was published on Tuesday, September 10, 2019. Mangold Insight has taken into account the company’s potential for the next 12 months. The report can be read in its entirety in Swedish only on the company’s website.
Cyxone AB (publ)
Kjell G. Stenberg, CEO
Tel: +46 (0) 723 816 168
211 22 Malmö, Sweden
Cyxone AB is a clinical stage biotech company with